Contact this trialFirst, we need to learn more about you.
CDK4/6 Inhibitor
Palbociclib + Fulvestrant for Breast Cancer
Recruiting1 awardPhase 2
Baltimore, Maryland
This trial is to see if continuing treatment with palbociclib and adding fulvestrant helps people with hormone-receptor positive breast cancer who have progressed on palbociclib and an aromatase inhibitor.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service